USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.08 | $-0.04 | $-0.20 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $18.42M | $17.84M | $9.47M |
Fortress Biotech's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 6 | $-0.08 | $-0.15 | $0.09 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 6 | $-0.32 | $-0.47 | $0.00 |
| Dec 2022 | 6 | $0.10 | $-1.01 | $1.14 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.08 | $-0.13 | $-0.13 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.32 | $-0.50 | $-0.50 |
| Dec 2022 | 0 / 0 | $0.10 | $0.06 | $0.06 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 6 | $19.95M | $15.15M | $22.50M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 6 | $67.78M | $59.73M | $71.80M |
| Dec 2022 | 6 | $103.03M | $24.15M | $205.30M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.08 | - | - |
| Aug 16, 2021 | Jun 2021 | $-0.17 | $-0.04 | 76.19% |
| May 16, 2021 | Mar 2021 | $-0.15 | $-0.11 | 25.42% |
| Mar 31, 2021 | Dec 2020 | $-0.14 | $-0.06 | 55.88% |
| Nov 9, 2020 | Sep 2020 | $-0.18 | $-0.20 | -11.11% |
| Aug 10, 2020 | Jun 2020 | $-0.23 | $-0.19 | 15.56% |
| May 11, 2020 | Mar 2020 | $-0.24 | $-0.19 | 20.83% |
| Mar 16, 2020 | Dec 2019 | $-0.28 | $-0.27 | 2.70% |
| Nov 12, 2019 | Sep 2019 | $-0.30 | $-0.22 | 26.67% |
| Aug 9, 2019 | Jun 2019 | $-0.46 | $-0.24 | 47.83% |
| May 10, 2019 | Mar 2019 | $-0.58 | $0.02 | 103.45% |
| Mar 18, 2019 | Dec 2018 | $-0.58 | $-0.58 | - |
| Nov 9, 2018 | Sep 2018 | $-0.57 | $-0.37 | 35.09% |
| Aug 9, 2018 | Jun 2018 | $-0.59 | $-0.50 | 14.78% |
| May 10, 2018 | Mar 2018 | $-0.40 | $-0.49 | -22.50% |
| Mar 16, 2018 | Dec 2017 | $-0.63 | $-0.21 | 66.40% |
| Nov 9, 2017 | Sep 2017 | $-0.43 | $-0.67 | -57.65% |
| Aug 9, 2017 | Jun 2017 | $-0.30 | $-0.43 | -45.76% |
| May 10, 2017 | Mar 2017 | $-0.36 | $-0.30 | 16.67% |
| Mar 16, 2017 | Dec 2016 | $-0.31 | $-0.44 | -41.94% |
| Nov 9, 2016 | Sep 2016 | $-0.20 | $-0.32 | -60.00% |
| Aug 9, 2016 | Jun 2016 | $-0.29 | $-0.31 | -6.90% |
| May 10, 2016 | Mar 2016 | - | $-0.31 | - |
| Mar 15, 2016 | Dec 2015 | $-0.09 | $-0.30 | -227.78% |
| Nov 9, 2015 | Sep 2015 | $-0.13 | $-0.46 | -253.85% |
| Aug 10, 2015 | Jun 2015 | $-0.14 | $-0.16 | -14.29% |
| May 11, 2015 | Mar 2015 | $-0.11 | $-0.31 | -181.82% |
| Mar 16, 2015 | Dec 2014 | - | $-0.10 | - |
| Nov 6, 2014 | Sep 2014 | - | $-0.13 | - |
| Aug 11, 2014 | Jun 2014 | $-0.18 | $-0.13 | 27.78% |
| May 12, 2014 | Mar 2014 | $-0.20 | $-0.21 | -5.00% |
| Mar 14, 2014 | Dec 2013 | $-0.22 | $-0.27 | -22.73% |
| Nov 1, 2013 | Sep 2013 | $-0.31 | $-0.24 | 22.58% |
| Aug 5, 2013 | Jun 2013 | $-0.34 | $-0.38 | -11.76% |
| May 8, 2013 | Mar 2013 | $-0.30 | $-0.35 | -16.67% |
| Mar 14, 2013 | Dec 2012 | $-0.28 | $-0.32 | -14.29% |
| Nov 14, 2012 | Sep 2012 | $-0.28 | $-0.24 | 14.29% |
| Aug 8, 2012 | Jun 2012 | $-0.40 | $-0.34 | 15.00% |
| May 15, 2012 | Mar 2012 | $-0.31 | $-0.35 | -12.90% |
| Mar 29, 2012 | Dec 2011 | $-0.32 | $-0.52 | -62.50% |
| Nov 30, 2011 | Sep 2011 | - | $-0.48 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $-0.73 | $-0.64 | - |
| Mar 16, 2020 | Dec 2019 | $-0.72 | $-0.71 | - |
| Mar 18, 2019 | Dec 2018 | $-1.96 | $-1.94 | - |
| Mar 16, 2018 | Dec 2017 | $-2.04 | $-1.61 | - |
| Mar 16, 2017 | Dec 2016 | - | $-1.38 | - |
| Mar 15, 2016 | Dec 2015 | - | $-1.23 | - |
| Mar 16, 2015 | Dec 2014 | - | $-0.57 | - |
| Mar 14, 2014 | Dec 2013 | - | $-1.24 | - |
| Mar 14, 2013 | Dec 2012 | - | $-1.25 | - |
| Mar 29, 2012 | Dec 2011 | - | $-1.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $18.42M | - | - |
| Aug 16, 2021 | Jun 2021 | $17.84M | $17.84M | 1.00% |
| May 16, 2021 | Mar 2021 | $13.41M | $11.59M | 0.86% |
| Mar 31, 2021 | Dec 2020 | $12.16M | $13.75M | 1.13% |
| Nov 9, 2020 | Sep 2020 | $11.32M | $9.47M | 0.84% |
| Aug 10, 2020 | Jun 2020 | $11.03M | $9.46M | 0.86% |
| May 11, 2020 | Mar 2020 | $11.29M | $12.92M | 1.14% |
| Mar 16, 2020 | Dec 2019 | $11.46M | $11.13M | 0.97% |
| Nov 12, 2019 | Sep 2019 | $8.23M | $9.77M | 1.19% |
| Aug 9, 2019 | Jun 2019 | $7.51M | $9.25M | 1.23% |
| May 10, 2019 | Mar 2019 | $6.41M | $6.48M | 1.01% |
| Mar 18, 2019 | Dec 2018 | $63.29M | $-156.07M | - |
| Nov 9, 2018 | Sep 2018 | $64.88M | $63.69M | 0.98% |
| Aug 9, 2018 | Jun 2018 | $48.93M | $63.83M | 1.30% |
| May 10, 2018 | Mar 2018 | $27.15M | $55.42M | 2.04% |
| Mar 16, 2018 | Dec 2017 | $48.03M | $45.32M | 0.94% |
| Nov 9, 2017 | Sep 2017 | $50.75M | $46.89M | 0.92% |
| Aug 9, 2017 | Jun 2017 | $44.10M | $50.70M | 1.15% |
| May 10, 2017 | Mar 2017 | - | $44.68M | - |
| Mar 16, 2017 | Dec 2016 | - | $12.62M | - |
| Nov 9, 2016 | Sep 2016 | - | $975.00K | - |
| Aug 9, 2016 | Jun 2016 | - | $2.23M | - |
| May 10, 2016 | Mar 2016 | - | $660.00K | - |
| Mar 15, 2016 | Dec 2015 | - | $338.00K | - |
| Nov 9, 2015 | Sep 2015 | - | $25.00K | - |
| Aug 10, 2015 | Jun 2015 | - | $500.00K | - |
| May 11, 2015 | Mar 2015 | - | $500.00K | - |
| Mar 16, 2015 | Dec 2014 | - | $0.00 | - |
| Nov 6, 2014 | Sep 2014 | - | $0.00 | - |
| Aug 11, 2014 | Jun 2014 | - | $0.00 | - |
| May 12, 2014 | Mar 2014 | - | $0.00 | - |
| Mar 14, 2014 | Dec 2013 | - | $0.00 | - |
| Nov 1, 2013 | Sep 2013 | - | $0.00 | - |
| Aug 5, 2013 | Jun 2013 | - | $0.00 | - |
| May 8, 2013 | Mar 2013 | - | $0.00 | - |
| Mar 14, 2013 | Dec 2012 | - | $0.00 | - |
| Nov 14, 2012 | Sep 2012 | - | $0.00 | - |
| Aug 8, 2012 | Jun 2012 | - | $0.00 | - |
| May 15, 2012 | Mar 2012 | - | $0.00 | - |
| Mar 29, 2012 | Dec 2011 | - | $0.00 | - |
| Nov 30, 2011 | Sep 2011 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $44.02M | $45.60M | 3.59% |
| Mar 16, 2020 | Dec 2019 | $36.96M | $36.63M | -0.90% |
| Mar 18, 2019 | Dec 2018 | $246.20M | $26.88M | -89.08% |
| Mar 16, 2018 | Dec 2017 | $189.60M | $187.58M | -1.06% |
| Mar 16, 2017 | Dec 2016 | - | $16.48M | - |
| Mar 15, 2016 | Dec 2015 | - | $863.00K | - |
| Mar 16, 2015 | Dec 2014 | - | $0.00 | - |
| Mar 14, 2014 | Dec 2013 | - | $0.00 | - |
| Mar 14, 2013 | Dec 2012 | - | $0.00 | - |
| Mar 29, 2012 | Dec 2011 | - | $0.00 | - |
FBIO's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 6 analysts, the average EPS estimation for Fortress Biotech's next quarterly earnings is $-0.08, with a low EPS estimation of $-0.16, and a high estimation of $0.06.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.08, the last 2 month trend is $-0.13, and the 3 month trend is $-0.13.
Based on 6 analysts, the average revenue estimation is $18.42M, with a low revenue estimation of $15.15M, and a high estimation of $20.90M.
Fortress Biotech's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.
FBIO's earnings per share (EPS) was $-0.04, beating the consensus analysts forecast of $-0.17 by 76.19%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -63.64%, and higher than the same period a year before (Jun 2020) by -78.95%.
Revenues were $17.84M, better than the forecast of $17.84M by 0.00%, up by 53.99% from the previous quarter , and up by 88.68% from the same period last year.
The company reported a net income of $-3.54M.Free cash flow for the quarter was $-39.30M , compared to $-22.15M last quarter and $-18.48M a year before.
FBIO ended the quarter with $86.50M in total debt, a decrease of -0.97% compared to the previous quarter, and a decrease of -5.23% compared to the same quarter a year before.
Fortress Biotech's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.
FBIO's earnings per share (EPS) was $-0.64, beating the consensus analysts forecast of $-0.73 by -12.33% , and higher than the previous year's EPS (Dec 2019) by -9.86%.
Revenues were $45.60M, better than the forecast of $44.02M by 3.59%, and up by 24.49% from previous year's revenue.
The company reported a net income of $-46.53M.
Fortress Biotech reported a free cash flow of $-90.85M for its fiscal year, compared to $-104.36M a year ago.
The company ended the fiscal year with $66.19M in total debt, a decrease of -27.61% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.